Drugs / Telenzepine
Telenzepine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01155531 | May → Aug 2010 | obesity disorder | Theracos | Completed | No outcome recorded |
Evidence & citations 7 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Telenzepine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01155531 ↗ |
| Known as | NSC-758679 | ChEMBL registry synonym — accepted as the source's own label CHEMBL253978 ↗ |
| Known as | Telenzepina | ChEMBL registry synonym — accepted as the source's own label CHEMBL253978 ↗ |
| Known as | TELENZEPINE DIHYDROCHLORIDE | ChEMBL registry synonym — accepted as the source's own label CHEMBL253978 ↗ |
| Known as | TELENZEPINE HYDROCHLORIDE | ChEMBL registry synonym — accepted as the source's own label CHEMBL253978 ↗ |
| Modality | Small molecule | — CHEMBL253978 ↗ |
| Route | Oral | “oral telenzepine capsules” NCT01155531 ↗ |